In December 2011, the company was successfully approved as “Jiangsu Bio-diagnostic Reagent Engineering Technology Research Center”, aimed to build an industrialized carrier of bio-diagnostic technology and services through open cooperation. Our company is investing 20 million yuan to build four technical platforms of immune chromatography, case diagnosis, flow cytometry and molecular diagnosis, and a registration platform of how to pass GMP.